Tecnimede Spain , the Spanish subsidiary of the Tecnimede Group, began trading in the Spanish pharmaceutical industry in 2009 with Tecnigen, the Group's brand focused on generic drugs.
From the very beginning, Tecnimede Spain has always maintained a policy of progressive expansion, in which each growth step is the result of prior work to consolidate the results that have already been achieved. Today, Tecnimede Spain boasts a business network that spans across the whole of Spain and facilitates the marketing of more than 84 different molecules, generating a total of more than 180 generic drug references.
Tecnimede Spain covers the most important therapeutic fields of the generic pharmaceutical industry, and most of its products are the result of its own research, development, and manufacturing, thanks to the Research and Development centre, Labor Qualitas, and the Atlantic Pharma production centre.
Since 2019, Tecnimede Spain has been going from strength to strength in the Spanish pharmaceutical sector, first with the launch of a line of over-the-counter medicines and then later with the launch of a range of dietary supplements.
Tecnimede Spain will continue to invest in healthcare through new developments and diversification within the Spanish pharmaceutical industry.
